World Allergy Organization Journal Volume 13, Issue 2 , February 2020

Alert: World Allergy Organization Journal New Articles available on ScienceDirect

World Allergy Organization Journal Volume 13, Issue 2 , February 2020

Ligustrum pollen: New insights into allergic disease Article Number 100104 Tania Robledo-Retana, Blessy M. Mani, Luis M. Teran

IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper Article Number 100080 Ignacio J. Ansotegui, Giovanni Melioli, Giorgio Walter Canonica, Luis Caraballo, ... Pascal M. Demoly

IgE responses to multiple allergen components among school-aged children in a general population birth cohort in Tokyo Article Number 100105 Kiwako Yamamoto-Hanada, Magnus P. Borres, Magnus K. Åberg, Limin Yang, ... Yukihiro Ohya

JAMA Livestream Q&A (Monday, March 16) Coronavirus (COVID-19) Testing – How To Interpret PCR Results

Coronavirus testing will help countries manage COVID-19 but will raise questions about how to counsel patients about their test results. The CDC’s Deputy Director for Infectious Diseases Jay Butler talks with JAMA Editor Howard Bauchner about what to advise healthy patients with positive tests, sick patients with negative test results, and more.

Optimizing Care For Your Patients With Atopic Dermatitis

This education from the AAAAI and The France Foundation offers 2 highly interactive cases—one focused on adults, the other on infants and children.

Diagnosis and Management in Adults BEGIN ACTIVITY Diagnosis and Management in Infants and Children BEGIN ACTIVITY

Both cases are immersive, practical, reflective of typical patients, and designed to boost your confidence and skills when it comes to the care of your patients with atopic dermatitis.

Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies?

Expert Review of Respiratory Medicine, DOI: 10.1080/17476348.2020.1733417

Philippe Devillier, Pascal Demoly & Mathieu Molimard

ABSTRACT

Key study periods examined in the retrospective, longitudinal,
real-world analysis of prescription records for grass pollen-associated
allergic rhinitis and asthma from the IMS Lifelink™
 Treatment Dynamics database

Introduction: Randomized controlled trials (RCTs) show that allergen immunotherapy (AIT) has proven long-term efficacy in patients with allergic rhinitis (AR). However, RCTs have limited generalizability and there is growing recognition that real-world evidence (RWE) is necessary to provide complementary data to those of RCTs, and corroborate their findings.

Development of a model care pathway for the management of Hymenoptera venom allergy: evidence-based key interventions and indicators

• Research
• Open Access

Clinical and Translational Allergy

• Maria Beatrice Bilò, 
• Alice Corsi, 
• Valerio Pravettoni, 
• Donatella Bignardi, 
• Patrizia Bonadonna, 
• Oliviero Quercia, 
• Marina Mauro, 
• Elio Novembre, 
• Rebecca Micheletti & 
• Roberto Papa 

Clinical and Translational Allergy volume 10, Article number: 8 (2020) 

• details

Abstract

Background

Hymenoptera venom allergy (HVA) is an underestimated condition representing an important cause of morbidity and mortality worldwide. Preventing future allergic reactions in patients who have already developed a systemic reaction is based on the correct management of the acute phase of the reaction followed by a correct diagnosis and, where indicated, prescription of adrenaline autoinjectors and VIT. A possible strategy to optimize care processes and to improve outcomes is the implementation of a Diagnostic and Therapeutic Care Pathways, also known as Integrated Care Pathways or Clinical Pathways (CPWs). The aim of the care pathway is to enhance the quality of care by improving risk‐adjusted patient outcomes, promoting patient safety, increasing patient satisfaction, and optimizing the use of resources. To our knowledge, currently in Italy as well as in Europe, there is no CPWs codified for the management of HVA patients. This paper describes the development of the clinical content of a care pathway for the management of HVA.

Relationship between serum inhibitory activity for IgE and efficacy of Artemisia pollen subcutaneous immunotherapy for allergic rhinitis: a preliminary self-controlled study

• Research
• Open Access

Allergy, Asthma & Clinical Immunology

• Wenping Wang, 
• Jinshu Yin, 
• Xueyan Wang, 
• Tingting Ma, 
• Tianfei Lan, 
• Qingkun Song & 
• Yifan Guo 

Allergy, Asthma & Clinical Immunology volume 16, Article number: 18 (2020) 

• details

Abstract

Background

Biomarkers of clinical efficacy for subcutaneous immunotherapy (SCIT) on allergic rhinitis (AR) have not been identified yet. This study aims to assess the clinical relevance of serum inhibitory activity for IgE by the method of enzyme-linked immunosorbent facilitated antigen binding (ELIFAB) during SCIT for Artemisia-sensitized AR patients.

Cetirizine use in childhood: an update of a friendly 30-year drug

• Review
• Open Access

Clinical and Molecular Allergy

• Giuseppe Fabio Parisi, 
• Salvatore Leonardi, 
• Giorgio Ciprandi, 
• Angelo Corsico, 
• Amelia Licari, 
• Michele Miraglia del Giudice, 
• Diego Peroni, 
• Carmelo Salpietro & 
• Gian Luigi Marseglia 

Clinical and Molecular Allergy volume 18, Article number: 2 (2020) 

• details

Abstract

Cetirizine is a second-generation antihistamine, derived from the metabolism of hydroxyzine, highly specific for the H1 receptors, and with marked antiallergic properties. Although its history began more than 30 years ago, it remains one of the most used drugs in children with a leading role in the medical care of children with allergic diseases. Cetirizine use is licensed for paediatric patients for the treatment of allergic rhinitis, and chronic spontaneous urticaria, in Europe in children older than 2 years old and in the USA in children older than 6 months old. This review provides a practical update on the use of cetirizine in children and adolescents.

Download PDF

A Precision Medicine Approach to Rhinitis Evaluation and Management

Agregar leyenda

Crisci, C.D., Ardusso, L.R.F. A Precision Medicine Approach to Rhinitis Evaluation and Management. Curr Treat Options Allergy (2020). https://doi.org/10.1007/s40521-020-00243-1

• details

Abstract

Purpose of Review

Precision medicine (PM) represents a new paradigm in disease diagnosis, prevention, and treatment. The PM approach focuses on the characterization of different phenotypes and pathogenic pathways in order to allow the selection of specific biomarkers that will be useful in disease management.

A Student Ate Gas Station Sushi For Breakfast. This Is What Happened To His Stomach.

Patient and physician perceptions of seasonal allergic rhinitis and allergen immunotherapy: a parallel physician patient survey

• Research
• Open Access

• Anne K. Ellis, 
• Jean Boursiquot, 
• Stuart Carr, 
• François Graham & 
• Marie-Soleil Masse 

Allergy, Asthma & Clinical Immunology volume 16, Article number: 15 (2020) 

• details

Abstract

Background

The Allergy Patient Identification for Immunotherapy (AsPIRe) program was a parallel physician and patient survey. The objectives were to examine physician and patient perceptions of seasonal allergy symptoms and their impact on patients, and to examine patient and physician attitudes to allergen immunotherapy (AIT) for seasonal allergies.

Study of atopic multimorbidity in subjects with rhinitis using multiplex allergen component analysis

Clinical and Translational Allergy

• Research
• Open Access
• 
  

• Viiu Blöndal, 
• Fredrik Sundbom, 
• Magnus P. Borres, 
• Marieann Högman, 
• Kjell Alving, 
• Andrei Malinovschi & 
• Christer Janson 

Clinical and Translational Allergy volume 10, Article number: 6 (2020)

Abstract

Background

Rhinitis is a common problem within the population. Many subjects with rhinitis also have atopic multimorbidity, such as asthma and eczema. The purpose of this investigation was to compare subjects with only rhinitis to those that have rhinitis, asthma and/or eczema in relation to immunoglobulin E (IgE) sensitization, inflammatory markers, family history, lung function and body mass index (BMI).

CME: Strategies for Success in Atopic Dermatitis Care

START ACTIVITY

Intended Audience: Physicians (PCPs, Pediatricians, Family Medicine, and Internal Medicine), Advanced Practitioners (NPs and PAs), Nurses, and Pharmacists

Listen in as Dr John Russell and a panel of renowned experts tackle pressing questions in atopic dermatitis (AD) care, offering their insightful perspectives to help you improve outcomes for your patients with AD.

Learn about:

• The latest clinical evidence and how it's shaping AD assessment, treatment, and management
• Pioneers in the field who are building bridges between specialty and primary care teams to optimize shared management of AD

Translating the Burden of Pollen Allergy Into Numbers: 10-Year Observational Study of Electronically Generated Symptom Data From the Patient’s Hayfever Diary in Austria and Germany

Original Paper

J Med Internet Res 2020;22(2):e16767

doi:10.2196/16767

Journal of Medical Internet Research

• Katharina Bastl¹, MSc, PhD ; 
• Maximilian Bastl¹, MSc, PhD ; 
• Karl-Christian Bergmann^2,3, MD ; 
• Markus Berger^1,4 ; 
• Uwe Berger¹, MBA 

¹Aerobiology and Pollen Information Research Unit, Department of Oto-Rhino-Laryngology, Medical University of Vienna, Vienna, Austria

²Foundation German Pollen Information, Berlin, Germany

³Department of Dermatology, Venerology and Allerogology, Charitè Universitätsmedizin, Berlin, Germany

⁴Paracelsus Medizinische Privatuniversität, Salzburg, Austria

ABSTRACT

Background: Pollen allergies affect a significant proportion of the population globally. At present, Web-based tools such as pollen diaries and mobile apps allow for easy and fast documentation of allergic symptoms via the internet.

Objective: This study aimed to characterize the users of the Patient’s Hayfever Diary (PHD), a Web-based platform and mobile app, to apply different symptom score calculations for comparison, and to evaluate the contribution of organs and medications to the total score for the first time.